Evaluation of ANCA in vasculitis and non-vasculitis diseases
Abstract
Keywords
Anti-neutrophil cytoplasmic antibody, MPO-ANCA, PR3-ANCA, vasculitis, connective tissue disease
References
- 1. Suwanchote S, Rachayon M, Rodsaward P, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin Rheumatol 2018;37:875-884. https://doi.org/10.1007/s10067-018-4062-x
- 2. Al Hussain T, Hussein MH, Conca W, Al Mana H, Akhtar M. Pathophysiology of ANCA-associated vasculitis. Adv Anat Pathol 2017;24:226-234. https://doi.org/10.1097/PAP.0000000000000154
- 3. Moiseev S, Tervaert JWC, Arimura Y, et al. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev 2020;19:102618. https://doi.org/10.1016/j.atrev.2020.102618
- 4. Van Beers JJBC, Vanderlocht J, Roozendaal C, Damoiseaux J. Detection of anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence. Methods Mol Biol 2019;1901:47-62. https://doi.org/10.1007/978-1-4939-8949-2_4
- 5. Sais G, Vidaller A, Jucgla A, Servitje O, Condom E, Peyrí J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol 1998;134:309-315. https://doi.org/10.1001/archderm.134.3.309
- 6. Kim JY, Choi H, Kim MK, Lee SB, Park YB, Lee SW. Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study. Rheumatol Int 2019;39:1927-1936. https://doi.org/10.1007/s00296-019-04397-3
- 7. Fteiha B, Bnaya A, Abu Sneineh M, Nesher G, Breuer GS. Clinical implications of ANCA positivity in a hospital setting: a tertiary center experience. Intern Emerg Med 2021;16:429-436. https://doi.org/10.1007/s11739-020-02518-6
- 8. Houben E, Bax WA, van Dam B, et al. Diagnosing ANCA-associated vasculitis in ANCA positive patients: a retrospective analysis on the role of clinical symptoms and the ANCA titre. Medicine 2016;95:e5096. https://doi.org/10.1097/MD.0000000000005096
- 9. Cornec D, Cornec Le Gall E, Fervenza FC, Specks U. ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 2016;12:570-579. https://doi.org/10.1038/nrrheum.2016.123
- 10. Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med 2021;16:831-841. https://doi.org/10.1007/s11739-021-02688-x
